FDA Seizes Drugmaker's Unapproved Topical Scar Treatment
Acting on a warrant signed by a California federal judge, the marshals on May 9 seized supplies of HybriSil, marketed by Vista, Calif.-based Crescendo Therapeutics LLC as a prescription topical corticosteroid gel to treat scars.
The agency didn't immediately say how much of the drug was seized.
Already a subscriber? Click here to login